Aims Arginine vasopressin (AVP) V 2 receptor antagonism is a new approach to the management of hyponatraemia in congestive heart failure (CHF). The aim of this study was to investigate the ...

In the present study, satavaptan 25 and 50 mg/day corrected dilutional hyponatraemia that was mainly secondary to CHF. Response rates were higher with satavaptan 25 and 50 mg/day than with placebo ...

For the five families of the dead children, the hyponatraemia inquiry has been a long and difficult road. The 14-year inquiry into hyponatraemia-related deaths which was published on Wednesday ...

It is understood to be a dilutional hyponatraemia caused by an increase of total body water relative to the amount of exchangeable sodium stores. Fourteen runners presented to one London hospital with ...